⌘K

Login Start Free

Home/Filings/4/0000874015-25-000228

4//SEC Filing

Baroldi Joseph 4

Accession 0000874015-25-000228

CIK 0000874015other

View on SEC.gov Company Profile

Filed

Sep 8, 8:00 PM ET

Accepted

Sep 9, 6:30 PM ET

Size

8.8 KB

Accession

0000874015-25-000228

Insider Transaction Report

Form 4

Period: 2025-09-05

IONIS PHARMACEUTICALS INCIONS

EVP, Chief Business Officer

Transactions

Exercise/Conversion
Common Stock
2025-09-05$31.80/sh+250$7,950→ 32,176 total
Sale
Common Stock
2025-09-05$62.00/sh−250$15,500→ 31,926 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-09-05−250→ 53,650 total
Exercise: $31.80From: 2023-01-31Exp: 2032-01-30→ Common Stock (250 underlying)

Holdings

Common Stock
(indirect: By Spouse)
3,071

Footnotes (1)

[F1]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 2, 2025.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

IONIS PHARMACEUTICALS INC

CIK 0000874015

Entity typeother

Related Parties

1

filerCIK 0001813775

Filing Metadata

Form type: 4
Filed: Sep 8, 8:00 PM ET
Accepted: Sep 9, 6:30 PM ET
Size: 8.8 KB

View on SEC.gov